Contact
Please use this form to send email to PR contact of this press release:
Neurimmune and TVM Capital Life Science Announce Creation of AL-S Pharma to Develop Innovative Therapy for Patients with ALS
TO:
Please use this form to send email to PR contact of this press release:
Neurimmune and TVM Capital Life Science Announce Creation of AL-S Pharma to Develop Innovative Therapy for Patients with ALS
TO: